Midkine Dependent Immunosuppressive Environment in Cerebrospinal Fluid May Promote Leptomeningeal Metastases of EGFR mutant NSCLC

被引：0

作者：

Li, Y. -S. ^{[1
]}

Yin, K. ^{[1
]}

Lai, W. -P. ^{[2
]}

Zheng, M. -M. ^{[1
]}

Tu, H. -Y. ^{[1
]}

Wang, Z. ^{[1
]}

Zeng, L. ^{[1
]}

Jiang, B. -Y. ^{[1
]}

Yang, J. -J. ^{[1
]}

Zhou, Q. ^{[1
]}

Zhong, W. -Z. ^{[1
]}

Yang, X. -N. ^{[1
]}

Chen, H. -J. ^{[1
]}

Wu, Y. -L. ^{[1
]}

机构：

[1] Southern Med Univ, Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst,Guangdong Prov Key Lab, Guangzhou, Peoples R China

[2] Jinan Univ, Inst Hematol, Sch Med, Guangzhou, Peoples R China

来源：

JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期

关键词：

Leptomeningeal metastases; immunosuppressive environment; midkine;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1.09-02

引用

页码：S199 / S200

页数：2

共 38 条

[1] Unique Genetic Profiles from Cerebrospinal Fluid Could Predict Survival of EGFR-Mutant NSCLC with Leptomeningeal Metastases
Li, Y.
Jiang, B.
Zheng, M.
Tu, H.
Yang, J.
Zhang, X.
Ye, J.
Zhou, Q.
Zhong, W.
Zhang, C.
Chuai, S.
Wu, Y.
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S482 - S482
[2] Unique Genetic Profiles from Circulating Cell-Free DNA of Cerebrospinal Fluid in Leptomeningeal Metastases of EGFR Mutant NSCLC
Jiang, B.
Li, Y.
Yang, J. -
Yang, X.
Zhou, Q.
Zhong, W.
Zhang, X.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1771 - S1771
[3] Genotyping of Cerebrospinal Fluid Associated With Osimertinib Response and Resistance for Leptomeningeal Metastases in EGFR-Mutated NSCLC
Zheng, Mei-Mei
Li, Yang-Si
Tu, Hai-Yan
Jiang, Ben-Yuan
Yang, Jin-Ji
Zhou, Qing
Xu, Chong-Rui
Yang, Xiao-Rong
Wu, Yi-Long
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (02) : 250 - 258
[4] ORA-LM: Molecular Analysis in Cerebrospinal Fluid of ALK or EGFR Positive NSCLC Patients with Leptomeningeal Metastases
van der Wel, T.
Boelens, M. C.
Jebbink, M.
Smulders, S. A.
Tiemessen, M. A.
Maas, K. W.
Luitse, M. J.
Compter, A.
Boltjes, R. P. B.
Sol, N.
Monkhorst, K.
van den Broek, D.
Smit, E. F.
de langen, A. J.
Brandsma, D.
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S354 - S355
[5] Osimertinib Improves overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastases
Ye, Qiuyue
Xu, Yan
Zhao, Jing
Gao, Xiaoxing
Chen, Minjiang
Pan, Ruili
Zhong, Wei
Wang, Mengzhao
TRANSLATIONAL ONCOLOGY, 2023, 31
[6] EGFR mutation status of paired cerebrospinal fluid and plasma samples in EGFR mutant non-small cell lung cancer with leptomeningeal metastases
Jing Zhao
Xin Ye
Yan Xu
Minjiang Chen
Wei Zhong
Yun Sun
Zhenfan Yang
Guanshan Zhu
Yi Gu
Mengzhao Wang
Cancer Chemotherapy and Pharmacology, 2016, 78 : 1305 - 1310
[7] EGFR mutation status of paired cerebrospinal fluid and plasma samples in EGFR mutant non-small cell lung cancer with leptomeningeal metastases
Zhao, Jing
Ye, Xin
Xu, Yan
Chen, Minjiang
Zhong, Wei
Sun, Yun
Yang, Zhenfan
Zhu, Guanshan
Gu, Yi
Wang, Mengzhao
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (06) : 1305 - 1310
[8] Osimertinib Leads the Way Toward Improving Outcomes of EGFR-Mutant NSCLC With Leptomeningeal Metastases
Zheng, Mei-Mei
Li, Yang-Si
Sun, Hao
Wu, Yi-Long
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (02) : E12 - E14
[9] Circulating Cell-Free DNA of Cerebrospinal Fluid May Function as Liquid Biopsy for Leptomeningeal Metastases of ALK Rearrangement NSCLC
Li, Y.
Jiang, B.
Yang, J. -.
Zhang, X.
Zhang, Z.
Zhou, Q.
Tu, H.
Wang, Z.
Chen, H.
Xu, C.
Wang, B.
Wu, Y.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1739 - S1739
[10] Genetic profiling of cell-free DNA from cerebrospinal fluid: opening the barrier to leptomeningeal metastasis in EGFR-mutant NSCLC
Vanden Bempt, I.
Wauters, E.
Vansteenkiste, J.
ANNALS OF ONCOLOGY, 2018, 29 (04) : 789 - 791

← 1 2 3 4 →